Few companies are having as bad a week as Ebix (EBIX), the insurance software company. Shares have fallen more than 50% now that Ebix is the subject of a criminal probe for intentional misconduct. As a result, the merger agreement Ebix had with Goldman Sachs (GS 1.58%) is off. Is this stock a value play or value trap? In this installment of Stock of the Day, Motley Fool analyst Charly Travers shares why he believes investors should let the dust settle from this investigation before adding Ebix to their watchlists.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Stock of the Day: Ebix
OTC: EBIX
Ebix

Shares of Ebix are cut in half in the past two days.
Charly Travers has no position in any stocks mentioned. Chris Hill has no position in any stocks mentioned. The Motley Fool recommends Ebix and Goldman Sachs. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned


*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles



Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.